Active Clinical Trials

Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)

By April 24, 2017 No Comments

Condition

Malignant Pleural Mesothelioma

Estimated Enrollment: 80

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment

Study ID Numbers: EF-23

Study First Received: March 19, 2015

Last Updated: March 28, 2017

Estimated Primary Completion Date: February 2018

 

Primary Outcome Measures:

Overall Survival|Progression Free Survival|Response Rate|Toxicity

Sponsors and Collaborators:

NovoCure Ltd.

Website Link: https://ClinicalTrials.gov/show/NCT02397928

Leave a Reply

Call Now